Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Bioxcel Therapeutics

BTAI

BTAI Bioxcel Therapeutics NASDAQ
Add to watchlist
--
At close : Jan 03, 16:00 ET
18.40
0.00 (0.00 %)
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    BTAI Chart
    See on advanced chart >
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --%
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
      --
      --
    • Day Range
      --
      --

    About

    Bioxcel Therapeutics, Inc. became a Delaware Corporation and a wholly owned subsidiary of BioXcel on March 29, 2017. BioXcel Therapeutics, Inc., or BTI, is a clinical-stage biopharmaceutical company focused on drug development that uses novel artificial...
    • Highlight
      A biopharmaceutical company developing novel therapeutics for neuroscience and immuno-oncology disorders
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/08/2018
    • Established Date
      03/29/2017
    • Full-time Employees
      74
    • Address
      555 Long Wharf Drive New Haven CT 06511
    • Tel
      1-475-2386837
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App